Ser1232

Site Information
QNsALPtssQDEELM SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 31862698

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	breast cancer ( 1 )
Relevant cell line - cell type - tissue:	BT-549 (breast cell) ( 1 ) , HeLa (cervical) ( 2 ) , MDA-MB-231 (breast cell) ( 1 )

References
1	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info
2	Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5 21712546 Curated Info
3	Ruse CI, et al. (2008) Motif-specific sampling of phosphoproteomes. J Proteome Res 7, 2140-50 18452278 Curated Info